IMPORTANCE Limbic encephalitis with leucine-rich, glioma-inactivated 1 (LGI1) antibodies is one of the most frequent variants of autoimmune encephalitis with antibodies targeting neuronal surface antigens. However, the neuroimaging pattern and long-term cognitive outcome are not well understood.
LGI1 antibodies develop limbic encephalitis and typically present with memory impairment, confusion, behavioral changes, and temporal lobe seizures. Faciobrachial dystonic seizures (FBDS), presenting as short, stereotyped dystonic movements of the face and the ipsilateral arm and/or leg, frequently precede the onset of anti-LGI1 encephalitis. 3 Early recognition and immunosuppressive treatment of FBDS can prevent progression to limbic encephalitis and development of cognitive deficits. 4, 5 Characteristic imaging features of autoimmune encephalitides associated with different antibodies are increasingly recognized. 6 For example, advanced imaging analyses, including resting-state functional magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), and volumetry, have revealed reduced hippocampal functional connectivity, widespread white matter damage, and hippocampal atrophy in encephalitis associated with N-methyl-D-aspartate receptor (NMDAR) antibodies despite normal results of clinical MRIs in most of these patients. 7, 8 Thus, these advanced analyses can provide relevant clinical and pathophysiologic information in autoimmune encephalitis. In anti-LGI1 encephalitis, results of clinical MRI at the stage of FBDS are frequently unremarkable, although basal ganglia abnormalities have been observed in some patients. 4, [9] [10] [11] During the limbic encephalitis stage of the disease, most patients develop T2 hyperintense signal alterations of the medial temporal lobes. [1] [2] [3] However, to our knowledge, no previous study has examined imaging correlates of anti-LGI1 encephalitis and their association with cognitive deficits and clinical outcome in detail.
In the present study, we investigated the effect of anti-LGI1 encephalitis on clinical and cognitive outcomes as well as the structure and function of the hippocampus and the basal ganglia in a cohort of 30 patients. We report (1) findings of routine clinical MRI; (2) neuropsychological outcome; (3) results of whole-brain, hippocampal, and basal ganglia volumetry; assessment of white matter integrity using DTI; gray matter morphology using voxel-based morphometry; and hippocampal microstructural integrity; and (4) correlation of structural imaging markers and onset of treatment with clinical and cognitive outcomes.
Methods

Patient Cohort
Thirty patients (11 women, 19 men; mean [SD] age, 65. 7 [12.3] years) with anti-LGI1 encephalitis from 2 centers using a unified study protocol were included in this study (eTable 1 in the Supplement) (Charité-Universitätsmedizin Berlin, Germany, 19 patients; University Hospital Schleswig-Holstein Kiel, Germany, 11 patients). Patients were recruited after the acute stage of limbic encephalitis (latency after disease onset: median, 23.3 months; interquartile range [IQR], 6.4-35.4 months). Three patients were not eligible for MRI studies, and imaging analyses were therefore restricted to 27 patients. Fludeoxyglucose F 18-positron emission tomography data on 4 patients were previously published.
12, 13 The imaging and neuropsychology control group comprised 27 healthy individuals without a history of psychiatric or neurologic disease. The control participants were individually matched to patients with respect to study site, sex, educational level, and age (9 women, 18 men; mean [SD] age, 64.3 [2. 3] years). There were no significant differences between patients and controls regarding age and years of formal education. The study was conducted from June 1, 2013, through February 28, 2015. The study was approved by the ethics committees of the Charité-Universitätsmedizin and the University Hospital Schleswig-Holstein. All participants provided written informed consent, and all received financial compensation.
Clinical Assessment
Neurologic disability and dependence in daily activities were scored using the modified Rankin Scale (mRS) 14 by 3 experienced neurologists (C.F., H.P., and T.B.). The scale is scored as 0, no symptoms; 1, no significant disability, able to carry out all usual activities despite some symptoms; 2, slight disability, able to look after own affairs without assistance but unable to carry out all previous activities; 3, moderate disability, requires some help but able to walk unassisted; 4, moderately severe disability, unable to attend to own bodily needs without assistance and unable to walk unassisted; 5, severe disability, requires constant nursing care and attention, bedridden, incontinent; and 6, death due to the condition. Latency from disease onset to treatment was calculated as the time between the onset of the first symptoms (eg, FBDS or autonomic seizures) and initiation of the first immunotherapy, and follow-up time was defined as the interval between the onset of the first symptoms and the time of the study (eTable 1 in the Supplement).
ence (Stroop test, 16 participants). To estimate the premorbid general intellectual ability, 25 patients performed the German equivalent of the National Adult Reading Test, scored from 0to37. 19 General reasoning abilities were evaluated using the German version of the Raven's Progressive Matrices (Leistungsprüfsystem, subtest logical thinking, 15 participants), scored from0to40. 20 The Montreal Cognitive Assessment test was administered for cognitive screening in 11 patients.
Antibody Testing
Serum samples and cerebrospinal fluid of the patients were tested for LGI1 antibodies by indirect immunofluorescence using a biochip mosaic containing, as antigenic substrates, frozen sections of rat hippocampus, rat and monkey cerebellum, and formalin-fixed HEK293 cells that expressed recombinant membrane-bound LGI1 (Euroimmun AG; Lübeck, Germany) ( Figure 1 ).
MRI Analyses
Detailed information about MRI acquisition and analysis is available in the eMethods in the Supplement. Imaging data were acquired at both study sites using 3-T MRI scanners. For the clinical study, previous brain MRIs (4-9 serial MRIs in all patients) were reevaluated with specific regard to hippocampal and basal ganglia signal changes by a neuroradiologist or experienced neurologist (C.F. and T.B.) blinded to the patient's diagnosis. Whole-brain DTI analysis using tract-based spatial statistics, hippocampal microstructural integrity analysis, and voxel-based morphometry were performed as described previously 7, 8 using the FMRIB Software Library (FSL, version 5.0; http://fsl.fmrib .ox.ac.uk/fsl/fslwiki) ( Figure 1 ). Volumes of the basal ganglia, whole hippocampus, and hippocampal subfields were determined using FreeSurfer, version 5.1 (http://surfer.nmr.mgh .harvard.edu/). FreeSurfer has been shown 21,22 to provide reliable and valid subcortical volumes, including hippocampal subfield segmentation, and to be more accurate than other automated methods in comparison with manual tracing. All volumes were adjusted within subject for intracranial volume.
Statistical Analysis
Psychometric test results were compared between groups using unpaired, 2-tailed t tests for independent samples or, if required, the Welch t test. Multivariate analyses of variance, with group as factor, age as covariate, and the 6 subfield volumes as dependent variables, were performed to analyze left and right hippocampal subfield volumes. Separate multivariate analyses of variance were used to assess whole left and right hippocampal volume and hippocampal mean diffusivity (MD). Bivariate correlation analyses were performed using parametric Pearson correlation for interval or ratio-scaled data and nonparametric Spearman rank correlation for ordinal data.
Results
Clinical Features
Clinical, laboratory, and electrophysiologic data of all patients are provided in the 
Clinical Imaging
Visual inspection of the acute routine MRI revealed unilateral or bilateral hippocampal T2/fluid-attenuated inversion recovery (FLAIR) hyperintensities in 22 of 30 patients (73%), transient diffusion restriction of bilateral posterior cortex in 1 patient (3%), and was normal or showed no specific abnormalities in 7 patients (23%) (median, 17 [IQR, 13-119] days after symptom onset) ( Figure 3 and Table) . One patient with normal MRI results exclusively showed FBDS that did not progress to limbic encephalitis. Follow-up routine MRI data were available for 26 patients and showed hippocampal atrophy in 25 patients (96%) on visual inspection ( Figure 3 ). In 13 of 26 patients (50%), hippocampal atrophy was accompanied by T2/ FLAIR signal increase and loss of internal laminar architecture indicating hippocampal sclerosis. Serial acute routine and 
Hippocampal Volumetry
Patients had a significantly reduced whole bilateral hippocampal volume in comparison with controls (eTable 2 in the Supplement). A multivariate analysis of variance of the left and right hippocampal volumes and their corresponding subfields revealed a significantly reduced volume of the right hippocampus in the patient group ( Figure 1 , Figure 4 , and eFigure 2 in the Supplement). Significant reductions of hippocampal subfield volumes in patients were observed bilaterally for cornu ammonis 2/3 (CA2/3), CA4/dentate gyrus (DG), presubiculum, and subiculum ( Figure 4 and eTable 2 in the Supplement). A decreased volume of the left CA2/3 subfield correlated significantly with deficits in the recall of the verbal memory material after interference (r = 0.40, P = .048) and delay (r = 0.40, P = .047) as well as during recognition (r = 0.42, P = .04) ( Figure 4 and eFigure 2 in the Supplement). Im- 
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Hippocampal Damage in Anti-LGI1 Encephalitis paired recognition was also associated with a decreased volume of the left subiculum (r = 0.42, P = .04). Patients with lower CA4/DG volumes were additionally more prone to commit intrusion errors during the recognition part of the RAVLT (r = −0.59, P = .03).
Hippocampal Microstructural Integrity
Patients 
Basal Ganglia Volumetry
Basal ganglia volumes were not significantly different between the patients and controls (eTable 2 in the Supplement). Right pallidum volume was negatively correlated with duration of FBDS (ie, days that FBDS persisted: r = −0.71, P = .03), with longer FBDS duration associated with smaller pallidum volume. The same trend was observed for all investigated basal ganglia volumes (all r < −0.30).
Voxel-Based Morphometry and DTI
Voxel-based morphometry analysis revealed no differences in cortical gray matter volume between the patient and control groups. No abnormalities in white matter microstructure were observed in the patient group compared with the control group with regard to the diffusion parameters fractional anisotropy, MD, axial diffusivity, and radial diffusivity.
Immunotherapy and Clinical Outcome
The latency between disease onset and initiation of immunotherapy was correlated with worse verbal and visuospatial episodic memory performance (RAVLT recall after interference: r = −0.48, P = .02; intrusions during recognition: r = 0.62, P = .03; ROCF: immediate recall, r =−0. 64,P = .02; and delayed recall, r =−0.46,P = .03) ( Figure 2 ). Higher mRS scores were associated with worse verbal memory performance (RAVLT delayed recall: r = −0.40, P = .049; recognition: r = −0.47, P = .02) ( Figure 2 ) and a higher susceptibility to errors on the Stroop task (r =0.66,P = .03). Moreover, higher dis- 
Discussion
We observed that patients with anti-LGI1 encephalitis had markedly impaired verbal and visuospatial memory in association with significantly reduced hippocampal volumes and impaired hippocampal microstructural integrity. Patients with more severe clinical outcomes had more structural hippocampal damage that in turn predicted worse memory performance. Patients with delayed treatment had worse verbal and visuospatial memory performance. Longer FBDS duration correlated with smaller pallidum volume.
Clinical and Cognitive Outcomes
Patients with anti-LGI1 encephalitis presented with typical clinical symptoms (ie, FBDS and limbic encephalitis) complemented by hyponatremia and characteristic hippocampal MRI signal changes. that found no tumor associations. Most patients with anti-LGI1 encephalitis respond to immunotherapy. 4, 5, 27, 28 Almost all of our patients received firstand second-line treatment. Despite this therapy, patients developed substantial verbal and spatial memory deficits. 1, 25 These neuropsychological deficits were correlated with disease severity, with higher mRS scores predisposing to worse performance. Memory deficits were more pronounced in patients who received second-line therapy, which likely relates to the higher disease severity in these individuals. Patients with later treatment had significantly worse memory outcomes. These results add to the observation 4 that early identification and immunosuppressive treatment of FBDS can prevent the subsequent development of cognitive deficits and mirror reports 29-31 of a significant correlation between treatment delay and cognitive outcome in NMDAR encephalitis and other autoimmune encephalitides. Consequently, testing for neuronal antibodies should be performed at a low threshold even in patients with normal findings on routine MRI. Our data furthermore suggest that pilomotor and autonomic seizures can be early symptoms of limbic encephalitis, which is in line with previous case reports 32-34 of patients with limbic encephalitis. Although an objective diagnosis of such seizures frequently cannot be achieved, we propose that antibody testing should be considered in patients presenting with paroxysmal shivering, flushing, or pilomotor erection. Despite possible severe adverse effects, all patients in the present study tolerated immunosuppression well, which is in line with findings from previous studies.
5,28
Neuroimaging
The hippocampus shows a selective vulnerability to metabolic and cytotoxic insults and is the major pathogenetic target in limbic encephalitis. [6] [7] [8] 35, 36 In our cohort, 97% of patients experienced memory deficits. Unilateral or bilateral hippocampal hyperintense signal alterations were found on acute and follow-up routine MRI of most patients, but the results of acute imaging were normal or showed no specific alterations in 23% of the patients. On follow-up, almost all patients had developed hippocampal atrophy or sclerosis, suggesting that hippocampal inflammation was present in the acute phase but not detectable by routine MRI. In contrast, we observed basal ganglia signal alterations in only 1 patient, and basal ganglia volumes were not reduced in comparison with those in healthy controls. However, longer individual FBDS duration correlated with reduced pallidum volume. This result adds to observations of basal ganglia positron emission tomography and MRI abnormalities and suggests a role for basal ganglia in FBDS pathophysiology.
3,4,10,11,50 We did not observe basal ganglia T1 and T2 hyperintensities that were recently reported in 42% of patients with anti-LGI1 encephalitis and FBDS. 11 This difference in basal ganglia MRI findings might be due to the transient nature of these signal alterations and the different timing of MRI in both studies. For example, T1 hyperintensities were detected a median of 26.5 days after FBDS onset with a median duration of 11 weeks, but T2 hyperintensities were seen after 15 days and lasted only 1 week. 11 Thus, longitudinal studies are needed to reveal the exact time course of these basal ganglia signal changes. Another recent study 50 reported hypermetabolism in the primary motor cortex contralateral to the limb affected by FBDS that normalized when the patients recovered. Using whole-brain voxel-based morphometry and DTI, we found no reduction of gray matter density and whole-brain white matter integrity. Specifically, we detected no structural damage in the motor cortex, corroborating the transient nature of motor cortex involvement in contrast to the severe and persistent hippocampal damage. Taken together, our MRI analyses provide a characteristic pattern of imaging alterations in anti-LGI1 encephalitis that reveal a more focal and less widespread pathophysiology in comparison with other autoimmune encephalitides. 6 The results particularly contrast with findings in anti-NMDAR encephalitis. The most prominent difference is widespread white matter damage in patients with anti-NMDAR encephalitis that was not observed in those with anti-LGI1 encephalitis despite the typical older age and the presence of microvascular white matter lesions on routine imaging in some of these patients. 8 Furthermore, although whole hippocampal volumes are reduced in both disorders, hippocampal subfields are differentially affected (bilateral atrophy of CA2/3, CA4/DG, subicular complex in anti-LGI1 encephalitis, and CA4/DG and subicular complex in anti-NMDAR encephalitis). 7 
Limitations
This study has limitations inherent to its exploratory and multicenter design. Patients were studied at 2 centers, and some neuropsychological tests were performed only in 1 center. However, major tests assessing memory, attention, and executive function were identical in both centers. Furthermore, a large number of imaging and neuropsychological analyses were performed. Given the exploratory nature of this study, no correction for multiple comparisons was performed across tests. However, corrections for multiple comparisons were performed for individual analyses where applicable (eg, voxel-based morphometry and DTI analyses) (eMethods in the Supplement).
Conclusions
We show that patients with anti-LGI1 encephalitis develop persistent and severe verbal and visuospatial memory deficits in addition to impairments of working memory, attention, and executive functions. Advanced imaging analyses revealed a characteristic pattern of bilateral hippocampal atrophy with predominant effects on the subfields CA2/3, CA4/DG, and the subicular complex and bilaterally impaired hippocampal microstructural integrity. Patients with more severe disease courses had a larger amount of hippocampal damage that in turn predicted worse memory performance. Duration of FBDS was associated with reduced pallidum volume. On clinical evaluation, we observed that 20% of patients presented with pilomotor or autonomic seizures-subtle clinical symptoms that need to be considered as possible signs of limbic encephalitis. Routine MRI during the acute disease stage revealed hippocampal hyperintensities in most patients but was unremarkable in 23% of the patients. Our data show that delayed immunotherapy is associated with more severe memory impairment and thus highlight the need for early diagnosis and rapid treatment in patients with anti-LGI1 encephalitis. 
MRI Acquisition
Imaging data was acquired at both sites using 3T MRI Scanners. At Charité University Hospital, a Siemens Tim
Trio scanner equipped with a 12-channel phased-array head coil (Siemens, Erlangen, Germany) at the Berlin Center for Advanced Neuroimaging was used. At University Hospital Schleswig-Holstein in Kiel, MRI data was acquired using a 32-channel head coil on a Philips Achieva scanner (Philips, Best, The Netherlands). At both sites, a high-resolution three-dimensional T1-weighted magnetization-prepared rapid gradient echo 
Analyses of clinical MRIs
For the clinical study, available previous brain MRIs from other institutions were re-evaluated by a neuroradiologist or neurologist experienced in the assessment of hippocampal signal abnormalities and blinded to the patient's diagnosis. Signal characteristics were assessed using T2-weighted or FLAIR images and were classified as "normal" or "hyperintense". Hippocampal volume was assessed by visual inspection and in comparison classified as "normal", "enlarged" or "atrophic". In follow-up images, T2/FLAIR signal increase and loss of internal laminar architecture in the cornu ammonis were used as criteria for diagnosing Ammon's horn sclerosis. All patients MRI's were also carefully evaluated with regard to signal changes in the basal ganglia in the acute, subacute and follow-up state to detect possible transient imaging changes. All patients had serial MRIs (4-9 MRIs) over the course of the disease. Signal abnormalities in the basal ganglia were longitudinally assessed with regard to hypo-or hyper intensities and volume changes in T1, T2, FLAIR and diffusion-weighted imaging.
Diffusion Tensor Imaging and hippocampal microstructural integrity
Differences in white matter integrity between patients and controls were investigated with diffusion tensor imaging. 1 The FMRIB Diffusion Toolbox as implemented in FSL 2 was used to assess fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD). Preprocessing steps included eddy current correction and brain extraction. Subsequently, a tensor model was fitted to the raw diffusion data.
The FA images were aligned to a 1x1x1 standard space, non-linearly registered to the group-specific template and narrowed to the FA skeleton. Cross-subject non-parametric permutation testing (5000 permutations) was conducted on a voxel-wise basis using the randomise tool as implemented in FSL. In order to account for different scanners at both sites, we included 'study site' as a covariate of no interest in the model. Thresholdfree cluster enhancement was applied (TFCE, p < 0.05, family-wise error corrected). Similarly, MD, AD and RD maps were determined using tract-based spatial statistics (TBSS).
In order to assess the microstructural integrity of the hippocampus and its relation to cognitive outcome, we conducted a region-of-interest analysis of the FA and MD maps in patients and controls. The left and right hippocampi were individually segmented from the brain extracted T1-weighted images using FSL FIRST, with the quality of the automated segmentation being controlled by visual inspection. 3 An affine linear ratio cost function transformation was used to register individual FA maps to the T1-weighted images. The resultant transformation matrices were then used for registration of MD maps. Finally, hippocampal masks were used for calculation of the mean individual hippocampal FA and MD values.
Voxel-based morphometry
The evaluation of differences in the local grey matter volume between patients and controls was carried out using FSL VBM. 4 MPRAGE images were brain extracted, segmented, aligned to MNI152 standard space using nonlinear registration and a study-specific template was created. Next, all native grey matter images were nonlinearly reregistered to this study-specific template. Further steps included modulation to correct for local expansion or contraction and smoothing with an isotropic Gaussian kernel ( = 3mm). The final voxel-wise
American Medical Association All rights reserved statistical analysis was performed with 'study site' as a covariate of no interest in the model and comprised non-parametric permutation testing with 5000 permutations and threshold-free cluster enhancement (TFCE) using FSL randomise (p < 0.05, FWE-corrected).
Hippocampal and basal ganglia volumetry
The Freesurfer image analysis suite (http://surfer.nmr.mgh.harvard.edu/) 5 was used to perform hippocampal and basal ganglia volumetry. Following motion correction and brain extraction, the images were segmented into subcortical white matter and grey matter volumetric structures including the hippocampal formation, caudate nucleus, putamen, globus pallidus and nucleus accumbens. Automated subfield segmentation of the hippocampus was performed using Bayesian inference and a probabilistic atlas of the hippocampal formation. 6, 7 The following subfield volumes were calculated: cornu ammonis CA1, CA2/3, CA4/dentate gyrus (DG), presubiculum, subiculum, and fimbria ( Fig. 1) . Volumes of the basal ganglia, whole hippocampus and hippocampal subfields were adjusted for intracranial volume (ICV) using the following formula: 
eFigure 2. (ippocampal Volumetry and Microstructural )ntegrity Analyses
A. Reduced mean volume of the cornu ammonis CA subfield in the patient group are associated with verbal memory deficits and an increased modified Rankin Scale mRS score B An increase in left hippocampal MD is accompanied by verbal memory deficits and higher mRS scores .
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